• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • DeviceTalks Weekly
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates
Home » Accuray dives despite beating The Street as losses gape | Earnings Roundup

Accuray dives despite beating The Street as losses gape | Earnings Roundup

November 9, 2011 By MassDevice staff

Accuray

Accuray (NSDQ:ARAY) shares are down today after the radiosurgery company reported surging first-quarter sales and beat Wall Street’s earnings expectations, as investors reacted to net losses of nearly six times the Q1 2011 mark.

Accuray reported losses of $26.5 million, or 38 cents per share, on sales of $100.5 million for the three months ended Sept. 30. That’s top-line growth of 163.9 percent compared with the same period last year, largely due to the massive infusion that followed ARAY’s acquisition of rival TomoTherapy earlier this year.

But losses from the just-closed quarter dwarfed last year’s levels, rising more than 471 percent compared with $4.6 million, or 8 cents per share, in Q1 2011.

Sign up to get our free newsletters delivered straight to your inbox

Still, The Street was looking for adjusted losses of 40 cents per share, which Accuray handily beat – adjusted to exclude one-time items, losses were $11.0 million, or 16 cents per share.

That didn’t stop investors from driving ARAY shares down to $4.03 as of about 11 this morning, from their $4.24 close yesterday, a 5.0 percent drop.

“We are pleased with the steady progress being made with integrating the two companies, highlighted by improving service gross margins,” said president & CEO Euan Thomson said in prepared remarks. “The strong revenue generated in the first quarter is reflective of the growing interest in both CyberKnife and TomoTherapy technologies.”

Accuray said it expects to post fiscal 2012 revenues of between $409 million and $424 million.

MassDevice.com Earnings Roundup

MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.

CardioNet’s Q3 sales slip, losses narrow
CardioNet (NSDQ:BEAT) managed to pare its losses by nearly 5 percent during the third quarter, despite a 3.2 percent sales decline.

The remote cardiac monitoring firm reported losses of $7.1 million, or 29 cents per share, on sales of $26.6 million for the three months ended Sept. 30.

That compared with losses of $7.5 million, or 31 cents per share, on sales of $27.5 million during the same period last year. Read more

Electromed’s Q1 sales surge, profits soar
First-quarter profits for Electromed (NSDQ:ELMD) soared 119 percent on a 29.1 percent sales increase.

The airway clearance therapy maker reported profits of $246,000, or 3 cents per share, on sales of $5.4 million for the three months ended Sept. 30.

That compares with profits of $112,000, or 2 cents per share, on sales of $4.2 million during the same period last year. Read more

Kips Bay’s Q3 losses widen as sales fall to zero
Kips Bay Medical (NSDQ:KIPS) posted wider losses during the third quarter as its sales slid to zero.

The company reported losses of $1.2 million, or 8 cents per share, on no sales during the three months ended Oct. 1.

That compares with losses of $733,000, or 5 cents per share, on sales of $37,000 during the same period last year. Read more

Nobel Biocare slashes Q3 losses
Nobel Biocare (VTX:NOBN) slashed its third-quarter losses by more than 87 percent despite a slight sales decline.

The Swiss dental devices maker logged losses of $3.1 million (€2.2 million), or 3 cents (€0.02), on sales of $174.3 million (€128.2 million)during the quarter.

That compares with losses of $24.2 million (€2.2 million), or 19 cents (€0.14) per share, on sales of $179.1 million (€131.7 million) during the same period last year. Read more

Bioject swings to Q3 black
Bioject Medical Technologies (OTC:BJCT) posted third-quarter profits on 106.8 percent sales growth.

The drug delivery device maker reported profits of $372,000, or 1 cent per share, on sales of $3.1 million during the three months ended Sept. 30.

That compares with losses of $357,000, or 2 cents per share, on sales of $1.5 million during the same period last year. Read more

Q3 losses soar for Echo Therapeutics
Third-quarter losses soared for Echo Therapeutics (NSDQ:ECTE) on negative sales growth.

The transdermal drug delivery developer reported losses of $1.5 million, or 4 cents per share, on sales of -$44,000 for the three months ended Sept. 30.

That compares with losses of $620,000, or 2 cents per share, on sales of $47,000 during the same period last year. Read more

CasMed’s Q3 losses surge on flat sales
Third-quarter losses for CAS Medical Systems (NSDQ:CASM) surged on flat sales.

The patient monitoring firm posted losses of $2.1 million, or 16 cents per share, on sales of $5.8 million during the three months ended Sept. 30.

That compares with losses of $508,000, or 4 cents per share, on sales of $5.8 million during the same period last year. Read more

Cutera narrows losses, grows sales
Cutera (NSDQ:CUTR) pared its third-quarter losses on sales growth of 26 percent.

The cosmetic device maker reported losses of $2.9 million, or 21 cents per share, on sales of $15.2 million during the three months ended Sept. 30.

That compares with losses of $3.5 million, or 18 cents per share, on sales of $12.1 million during the same period last year. Read more

IntriCon swings to Q3 red
IntriCon (NSDQ:IIN) logged third-quarter losses on a 5.8 percent sales slide.

The miniature medical device maker reported losses of $489,000, or 9 cents per share, on sales of $13.9 million.

That compares with profits of $243,000, or 4 cents per share, on sales of $14.7 million during the same period last year. Read more

Tornier’s Q3 sales jump as it slashes losses
Tornier (NSDQ:TRNX) slashed its third-quarter losses via a 15.8 percent sales boost.

The extremity joint replacement company posted losses of $1.6 million, or 4 cents per share, on sales of $57.6 million for the three months ended Oct. 2.

That compares with losses of $12.8 million, or 43 cents per share, on sales of $49.7 million during the same period last year. Read more

BioMimetic Therapeutics shaves losses on sales growth
BioMimetic Therapeutics (NSDQ:BMTI) shaved 8.1 percent off its third-quarter losses with 21.4 percent sales growth.

The biotech firm reported losses of $7.1 million, or 25 cents per share, on sales of $429,000 for the three months ended Sept. 30.

That compares with losses of $7.8 million, or 29 cents per share, on sales of $353,000 during the same period last year. Read more

Pro-Dex
Pro-Dex posts Q1 sales, earnings growth
Pro-Dex (NSDQ:PDEX) logged first-quarter growth for both its top and bottom lines.

The surgical device drive maker reported profits of $446,000, or 14 cents per share, on sales of $6.0 million during the three months ended Sept. 30.

That compares with profits of $342,000, or one thin dime per share, on sales of $5.8 million during the same period last year. Read more

Misonix logs Q1 sales growth, narrows losses Misonix (NSDQ:MSON) narrowed its first-quarter losses on 14.8 percent sales growth.

The ultrasound device maker reported losses of $884,000, or 13 ce3nts per share, on sales of $3.7 million during the three months ended Sept. 30.

That compares with losses of $1.0 million, or 15 cents per share, on sales of $3.3 million during the same period last year. Read more

Filed Under: MassDevice Earnings Roundup, News Well, Radiosurgery/Radiation therapy Tagged With: Accuray Inc., Bioject Medical Technologies Inc., BioMimetic Therapeutics Inc., CardioNet Inc., CAS Medical Systems Inc., Cutera Inc., Echo Therapeutics Inc., Electromed, IntriCon Corp., Kips Bay Medical Inc., Misonix, Nobel Biocare Holdings AG, Pro-Dex Inc., Q3, Tornier Inc.

In case you missed it

  • DiaSorin to buy Luminex for $1.8B
  • Genentech wins FDA approval for Xolair prefilled syringe
  • FDA slaps Class I label on rapid infuser recall
  • Microsoft spending $19.7B on Nuance and its AI for healthcare providers
  • Memic raises $96M to support surgical robot with humanoid-shaped arm
  • Heater-Cooler suit against LivaNova revived
  • Cardiovascular Systems completes minority investment in CarePICS with option to buy
  • Zoll Medical acquires Respicardia
  • Medtronic has a serious recall of ICDs and CRT-Ds
  • Lyra Therapeutics touts results from chronic rhinosinusitis treatment trial
  • FDA issues EUA for single-use, OTC PCR COVID-19 at-home test
  • AI-aided colon cancer tech gets FDA nod
  • MedTech 100 roundup: Industry roars back
  • DTW Podcast: Herrera on how military lessons led to Medtech career; Ulmer ready to redo landmark FDA survey
  • EMA begins investigation of J&J COVID-19 vaccine’s blood clotting potential
  • Johnson & Johnson COVID-19 vaccine shipments plunge
  • Medtronic stent graft recall is serious

RSS From Medical Design & Outsourcing

  • Cretex breaks ground on new plant north of Minneapolis
    Cretex Cos. last week broke ground on a new 245,000 ft2 medical device contract manufacturing plant in Brooklyn Park, Minn. Elk River, Minn.–based Cretex plans to complete facility construction by the end of the year. The company expects the facility by the end of 2022 to house its stamping, molding and tool design — and… […]
  • Resonetics to expand manufacturing in Costa Rica
    Resonetics announced today it has leased new manufacturing space in Costa Rica to more than double its production there. The space, in a building near its current site in the Coyol Free Zone business park in Alajuela, will be expanded and reconfigured to create a 45,000 ft² production site. The move comes after the company… […]
  • Are Black patients not getting LVADs as quickly as white patients?
    Researchers from the University of Missouri conducted a study that found disparities in treating Black and white patients with advanced heart failure. According to a news release, the study found that Black patients with advanced heart failure were more likely to receive a left ventricular assist device (LVAD) — a pump implanted into the chest… […]
  • Viant expands factory in Costa Rica
    Viant announced today that it has completed a major expansion of its medical device manufacturing facility in Heredia, Costa Rica. The company said it invested in the additional capacity to meet market demand for minimally invasive surgical devices, including energy-based devices. Begun in fall 2020, the expansion adds 14,000 ft² of ISO Class 8 cleanroom… […]
  • St. Jude Medical founder and his Medical 21 raise $3M
    Raising money for a startup company during a pandemic is no cakewalk, according to Manny Villafaña. But he did it. Medical 21, the latest venture for the founder of St. Jude Medical, has raised another $3 million in an equity offering, according to an SEC filing. The most recent round brings the Minneapolis-based startup’s total funding… […]
  • How can patient input improve clinical trials?
    The Medical Device Innovation Consortium (MDIC) has laid out some recommendations for improving medical device clinical trials with increased patient input. Having observed that clinical trial sponsors seldom refer to patient input — something the FDA issued guidance for in September 2019 — MDIC offered its view on increasing and using patient input to improve… […]
  • Orchid names new CFO
    Orchid Orthopedic Solutions (Holt, Mich.) announced this week that Matt Tharp has joined the company as chief financial officer. Tharp comes to Orchid from Ammega, where he held the role of CFO – Americas. He has more than 20 years of experience in supply chain, operations and finance and has held leadership roles at Midwest… […]
  • ICS establishes dedicated medical device practice
    Integrated Computer Solutions (ICS) is establishing a dedicated medical device practice amid increased demand for complex medtech. ICS said its work in the medical and life sciences markets has nearly doubled year-over-year as connected technologies drive innovation and transform healthcare. “There has been extraordinary innovation and growth in the medtech sector in recent years which… […]
  • SMC is expanding its Costa Rica facility
    SMC (Somerset, Wis.) recently announced that it will double the size of its Alajuela, Costa Rica facility to 120,000 ft2 this year. The additional space will enable SMC Costa Rica to provide increased contract manufacturing solutions, including assembly, injection molding and secondary operations. SMC plans to double the number of workers it has in the Central… […]
  • Sandia Labs seeks partners to make reusable masks
    Sandia National Laboratories has come up with its own version of a reusable respirator for frontline workers. Sandia has filed for patent protection, is testing prototypes, and seeking NIOSH approval and potential manufacturing partners for its elastomeric half-mask N95 respirator. It’s the latest entry to a small but growing category of reusable masks designed to… […]
  • Evco Plastics adds Ga. plant for medtech production
    Evco Plastics (DeForest, Wis.) announced today that it recently purchased a new facility for white room and liquid silicone rubber molding near Calhoun, Ga. The CAL 2 facility has room for 20 injection molding machines of up to 500 tons, and there will be a separate room for new LSR machines. Other features of CAL… […]

Leave a Reply Cancel reply

You must be logged in to post a comment.

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS